Sharing your complete health history during the initial assessment is important for safe, effective care
Sound mechanistic evidence supports the need for further research on the GLP1-RAs/SGLT2is combinations ability to modify specific risk outcomes, such as cardiovascular risk and the progression of diabetic kidney disease
Visit megaphone.fm/adchoices Day 278 Essentials: The Science & Practice of Perfecting Your Sleep In this Huberman Lab Essentials episode my guest is Dr
a method of chronic weight management as embodied by Embodiment 31 comprising Administering to said subject a once weekly dose of a compound of SEQ ID NO:2 that is 20 mg for a minimum of four weeks
GLP-1 medications work through several complementary mechanisms: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels Suppressing glucagon release , thereby reducing hepatic glucose production Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on appetite centres in the brain , leading to reduced caloric intake and weight loss Commonly prescribed GLP-1 receptor agonists available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus [oral form]), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)
